Hudson Bay Capital Management LP Acquires Shares of 250,000 Sotera Health Company $SHC

Hudson Bay Capital Management LP bought a new position in shares of Sotera Health Company (NASDAQ:SHC) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 250,000 shares of the company’s stock, valued at approximately $3,932,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Versant Capital Management Inc raised its position in shares of Sotera Health by 117.6% in the third quarter. Versant Capital Management Inc now owns 2,535 shares of the company’s stock valued at $40,000 after buying an additional 1,370 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after buying an additional 2,935 shares in the last quarter. Fairway Wealth LLC bought a new position in Sotera Health during the 3rd quarter worth $57,000. CWM LLC increased its stake in Sotera Health by 194.6% during the 3rd quarter. CWM LLC now owns 5,191 shares of the company’s stock worth $82,000 after acquiring an additional 3,429 shares during the period. Finally, Quadrant Capital Group LLC acquired a new position in Sotera Health in the 3rd quarter valued at $86,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. William Blair initiated coverage on Sotera Health in a research report on Thursday, December 18th. They set an “outperform” rating for the company. Piper Sandler raised Sotera Health from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $17.00 to $24.00 in a research note on Friday, January 9th. Citigroup upped their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Zacks Research downgraded shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Sotera Health in a report on Monday, December 29th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $20.43.

Sotera Health Trading Down 0.4%

Shares of SHC stock opened at $13.50 on Friday. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $19.85. The stock’s fifty day moving average price is $16.83 and its two-hundred day moving average price is $16.66. The company has a debt-to-equity ratio of 3.66, a quick ratio of 2.24 and a current ratio of 2.46. The company has a market cap of $3.84 billion, a PE ratio of 50.00 and a beta of 1.84.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The company had revenue of $303.44 million during the quarter, compared to analysts’ expectations of $300.68 million. During the same quarter in the previous year, the firm earned $0.21 EPS. Sotera Health’s revenue was up 4.6% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Equities analysts predict that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the transaction, the director owned 12,735,301 shares in the company, valued at $194,468,046.27. The trade was a 43.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 47.55% of the stock is currently owned by corporate insiders.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.